ATNF

Q: What is the price of 180 Life Sciences (ATNF) today?

The current price of 180 Life Sciences (ATNF) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does 180 Life Sciences (ATNF) pay dividends?

180 Life Sciences (ATNF) did not pay dividends over the past year.

180 Life Sciences Corp.

Price

$ -

return (12m)

0.00%

p/e

-4.59

p/bv

7.85

DIVIDEND YIELD

0.00%

ATNF price

ATNF

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ATNF

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ATNF

review the fundamentals of 180 Life Sciences shares

P/E

-4.59

Sector: -4.09 Industry: -4.09

P/S (PSR)

Sector: -3.87 Industry: -3.87

P/BV

7.85

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-85.99%

Sector: -61.28% Industry: -61.28%

ROE

-171.19%

Sector: -61.00% Industry: -61.00%

ROIC

-82.35%

Sector: -2,142.55% Industry: -2,142.55%

NET MARGIN

0.00%

Sector: -39.07% Industry: -39.07%

GROSS MARGIN

0.00%

Sector: 37.83% Industry: 37.83%

OPERATING MARGIN

0.00%

Sector: -39.17% Industry: -39.17%

EV/EBITDA

-4.47

Sector: -3.91 Industry: -3.91

EV/EBIT

-4.46

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

3.94

Sector: 1.39 Industry: 1.39

BVPS

0.90

Sector: 1.88 Industry: 1.88

EPS

-1.54

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.50

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-14.64%

Sector: - Industry: -

Fundamentals ATNF

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.01	6.74	25.92%	2.29%	$ 547.30 B	21.83%
PFE	19.27	1.61	8.35%	6.53%	$ 149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$ 365.48 B	5.79%
NVO	12.44	6.41	51.50%	4.25%	$ 194.87 B	33.05%
MRK	31.01	0.00	0.00%	2.96%	$ 277.04 B	13.59%
AZN	27.54	6.04	21.93%	1.73%	$ 286.16 B	17.19%
GILD	19.21	7.23	37.62%	2.42%	$ 163.51 B	28.90%
BMY	16.31	0.00	0.00%	4.29%	$ 118.65 B	15.01%
ZTS	18.71	15.01	80.25%	1.78%	$ 50.00 B	28.23%
REGN	16.49	2.32	14.08%	0.51%	$ 72.95 B	29.65%
HALO	23.82	154.63	649.21%	0.00%	$ 7.55 B	22.69%
AMGN	22.83	19.38	84.87%	2.93%	$ 178.10 B	20.96%
MCK	23.07	-1,011.36	-4,383.84%	0.39%	$ 100.12 B	1.09%
VRTX	27.24	5.77	21.18%	0.00%	$ 107.68 B	32.94%
HRMY	11.43	2.08	18.24%	0.00%	$ 1.81 B	18.27%
CAH	29.51	-17.17	-58.20%	1.05%	$ 45.88 B	0.62%
ADMA	17.04	5.25	30.78%	0.00%	$ 2.50 B	28.80%
BIIB	20.04	1.47	7.36%	0.00%	$ 27.50 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ATNF Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT 180 Life Sciences

180 Life Sciences Corp.

Average Investor10 user rating

4.0 (1 people)

United States

9 years

Founded: 2017

Time since IPO - - year

-

Employees

180 Life Sciences Corp. (United States) is listed on the Nasdaq and has a market capitalization of $42.24 Millions, with shareholders equity totaling $5.38 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, 180 Life Sciences Corp. reported $- in revenue, generating net income of $-9.21 Millions.

Key financial metrics include a P/E ratio of -4.59, a price-to-book (P/B) ratio of 7.85, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ATNF.

Market cap

$ 42.24 Millions

Net worth

$ 5.38 Millions

$ 5,380,000.00

Assets

$ 10.71 Millions

$ 10,710,000.00

Total Shares Outstanding

6.00 Millions

6,000,000

Average Daily Trading Volume

$ 10.17 Millions

$ 10,169,516.00

Sector

Health Care

Industry

Biotechnology

ATNF

ATNF revenue and profits

Financial Results ATNF

DRAG THE FRAME TO SEE MORE DATA

ATNF cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 807.85 14,83% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$ 197.06 31,12% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$ 224.20 49,56% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$ 26.30 20,14% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$ 113.11 41,50% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 183.46 32,89% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$ 208.16 10,55% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 807.85 14,83% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$ 197.06 31,12% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$ 224.20 49,56% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$ 26.30 20,14% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$ 113.11 41,50% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 183.46 32,89% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$ 208.16 10,55% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of 180 Life Sciences (ATNF) today?

The current price of 180 Life Sciences (ATNF) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does 180 Life Sciences (ATNF) pay dividends?

180 Life Sciences (ATNF) did not pay dividends over the past year.

Is 180 Life Sciences (ATNF) a good investment?

180 Life Sciences (ATNF) is currently trading at $ 0.00 with a P/E ratio of -4.59%. This represents a -170% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy 180 Life Sciences (ATNF) stock?

You can buy 180 Life Sciences (ATNF) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ATNF and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of 180 Life Sciences (ATNF) yield today?

Over the past month, 180 Life Sciences (ATNF) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of 180 Life Sciences (ATNF) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ATNF

180 Life Sciences Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ATNF

review the fundamentals of 180 Life Sciences shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT 180 Life Sciences

180 Life Sciences Corp.

United States

9 years

-

PROFIT X PRICE ATNF

Financial Results ATNF

ATNF cash flow

Asset, Revenue and Profit Growth - ATNF

ATNF balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions